| Khdrbs3 |
Mus musculus |
|
Khdrbs3 is differentially expressed in 71 experiments [87 up/86 dn]: 61 organism parts: liver [6 up/3 dn], hippocampus [5 up/0 dn], ...; 3 disease states: normal [1 up/0 dn], monoclonal gammopathy of undetermined significance (MGUS) [0 up/1 dn], ...; 16 cell types, 9 compound treatments, 2 clinical treatments and 9 other conditions. |
| Khdrbs3, Salp, Slm2 |
|
qkr58E-2 (Drosophila melanogaster)
qkr54B (Drosophila melanogaster)
CG10384 (Drosophila melanogaster)
CG3875 (Drosophila melanogaster)
MSL5 (Saccharomyces cerevisiae)
Y69A2AR.32 (Caenorhabditis elegans)
K07H8.9 (Caenorhabditis elegans)
CG3927 (Drosophila melanogaster)
CG4021 (Drosophila melanogaster)
qkr58E-1 (Drosophila melanogaster)
qkr58E-3 (Drosophila melanogaster)
KHDR3_RAT (Rattus norvegicus)
KHDRBS3 (Homo sapiens)
(Compare orthologs)
|
|
|
| K Homology |
|
|
| RNA binding, SH3 domain binding, nucleus, transcription, regulation of transcription |
|
|
|
Q9R226
|
|
|
|
ENSMUSG00000022332
|
|
|
| Factor Value |
Factor |
Up/Down |
Legend: - number of studies the gene is up/down in
|
|
Liver
|
Organism part |
|
|
Wild_type
|
Genotype |
|
|
Hippocampus
|
Organism part |
|
|
Hypothalamus
|
Organism part |
|
|
Kidney
|
Organism part |
|
|
Testis
|
Organism part |
|
|
Amygdala
|
Organism part |
|
|
Pancreas
|
Organism part |
|
|
Spleen
|
Organism part |
|
|
Ovary
|
Organism part |
|
|
E13.5
|
Developmental stage |
|
|
Control
|
Compound treatment |
|
|
Lipopolysaccharide
|
Compound treatment |
|
|
Colon
|
Organism part |
|
|
Embryo
|
Developmental stage |
|
|
Adult
|
Developmental stage |
|
|
Pituitary gland
|
Organism part |
|
|
Jejunum
|
Organism part |
|
|
Periaqueductal gray
|
Organism part |
|
|
CD8+ T cell
|
Organism part |
|
|
CD4+ T cell
|
Organism part |
|
|
Ileum
|
Organism part |
|
|
Cerebellum
|
Organism part |
|
|
Forebrain
|
Organism part |
|
|
CBA/CaJ
|
Strain or line |
|
|
C57BL/6J
|
Strain or line |
|
|
B220+ B cell
|
Organism part |
|
|
Cerebral cortex
|
Organism part |
|
|
PKB alpha null
|
Genotype |
|
|
Fertilized egg
|
Organism part |
|
|
Oocyte
|
Organism part |
|
|
Frontal cortex
|
Organism part |
|
|
Main olfactory epithelium
|
Organism part |
|
|
Skeletal muscle
|
Organism part |
|
|
Thyroid
|
Organism part |
|
|
Thymus
|
Organism part |
|
|
Lymph node
|
Organism part |
|
|
Sertoli cell
|
Cell type |
|
|
Spermatocyte
|
Cell type |
|
|
Blastocysts
|
Organism part |
|
|
Digits
|
Organism part |
|
|
Spermatogonium
|
Cell type |
|
|
Medial gastrocnemius
|
Organism part |
|
|
Lacrimal gland
|
Organism part |
|
|
BALB
|
Strain or line |
|
|
B6
|
Strain or line |
|
|
Quadriceps muscle
|
Organism part |
|
|
Retina
|
Organism part |
|
|
GABAergic interneuron
|
Cell type |
|
|
Dorsal striatum
|
Organism part |
|
|
Mock control
|
Infection |
|
|
Theiler's murine encephalomyel...
|
Infection |
|
|
Pituitary
|
Organism part |
|
|
Both ventricles
|
Organism part |
|
|
Small intestine
|
Organism part |
|
|
E15.5
|
Developmental stage |
|
|
Quadriceps skeletal muscle
|
Organism part |
|
|
Litter 2
|
Generation |
|
|
Litter 1
|
Generation |
|
|
Heart
|
Organism part |
|
|
Dinitrofluorobenzene
|
Compound treatment |
|
|
Rostral to trauma
|
Observation |
|
|
Vomeral nasal organ
|
Organism part |
|
|
Atrial chamber
|
Organism part |
|
|
CHF1/Hey2 null
|
Genotype |
|
|
Adipose tissue
|
Organism part |
|
|
Placenta
|
Organism part |
|
|
Dorsal root ganglion
|
Organism part |
|
|
Anti-CD3 and anti-CD28 antibod...
|
Compound treatment |
|
|
Normal
|
Disease state |
|
|
Adrenal gland
|
Organism part |
|
|
Embryonic stem cell
|
Cell type |
|
|
Hematopoietic stem cell
|
Cell type |
|
|
Epidermis
|
Organism part |
|
|
E16.5
|
Developmental stage |
|
|
Lateral geniculate nucleus (th...
|
Organism part |
|
|
SCA1 knock-in
|
Genotype |
|
|
R6/1 transgenic
|
Genotype |
|
|
Resistant
|
Phenotype |
|
|
Susceptible
|
Phenotype |
|
|
Umbilical cord
|
Organism part |
|
|
Pachytene spermatocyte
|
Cell type |
|
|
Spermatid
|
Cell type |
|
|
Spinal cord upper
|
Organism part |
|
|
Cycloheximide (pretreatment)+ ...
|
Compound treatment |
|
|
Bed nucleus of the stria termi...
|
Organism part |
|
|
C57BL/6
|
Strain or line |
|
|
Microglial cell
|
Cell type |
|
|
None
|
Compound treatment |
|
|
Bladder
|
Organism part |
|
|
Preoptic
|
Organism part |
|
|
AKT transgenic
|
Genotype |
|
|
Multiple myeloma tumour cell
|
Cell type |
|
|
B220+ B cell
|
Cell type |
|
|
Monoclonal gammopathy of undet...
|
Disease state |
|
|
Multiple myeloma
|
Disease state |
|
|
SCA7 wild_type
|
Genotype |
|
|
Substantia nigra
|
Organism part |
|
|
Primary chondrocyte
|
Cell type |
|
|
Anterior tibialis
|
Organism part |
|
|
Control
|
Infection |
|
|
Mycobacterium tuberculosis
|
Infection |
|
|
Trigeminal
|
Organism part |
|
|
Resting natural killer cells
|
Cell type |
|
|
Glutamatergic neuron
|
Cell type |
|
|
Olfactory bulb
|
Organism part |
|
|
Germ cell
|
Cell type |
|
|
Mock infected
|
Infection |
|
|
Chlamydia pneumoniae
|
Infection |
|
|
Mammary gland
|
Organism part |
|
|
Bmal1-/-
|
Genotype |
|
|
P48-Cre;KrasG12D
|
Genotype |
|
|
Gata-1(-/-)
|
Genotype |
|
|
Constant darkness
|
Light |
|
|
12 h light:12 h dark
|
Light |
|
|
ALDHhiSSClo neural stem cells ...
|
Clinical treatment |
|
|
Untreated
|
Clinical treatment |
|
|
SCA7 knock-in
|
Genotype |
|
|
E14.5
|
Developmental stage |
|
|
E18.5
|
Developmental stage |
|
|
Pam2CSK4
|
Compound treatment |
|
|
Pam3CSK4 + poly I:C
|
Compound treatment |
|
|
Activated natural killer cells
|
Cell type |
|
|
SCA1 wild_type
|
Genotype |
|
|
Brown fat
|
Organism part |
|
|
Prostate
|
Organism part |
|
|
Connexin 30-/-
|
Genotype |
|
|
Site of trauma
|
Observation |
|
|
N-(1-naphthyl)ethylenediamine ...
|
Compound treatment |
|
|
TICAM1(-/-)
|
Genotype |
|
|
T8 spindal segment
|
Organism part |
|
|
PGC-1 beta transgenic
|
Genotype |
|
|
MKK7D transgene induced
|
Genotype |
|
|
Starved
|
Growth condition |
|
|
Control
|
Growth condition |
|
|
|
|
|
Processing time: 0.145 secs.